UK investor profile and portfolio
SR One
4 UK company relationship(s) retained from funding evidence.
2 as lead
UK portfolio companies
- Bicycle TherapeuticsEast of England
- Charm TherapeuticsLondon
- MiroBioSouth East
- Mission TherapeuticsEast of England
Sources
- https://charmtx.com/charm-therapeutics-raises-80-million-in-series-b-financing-to-advance-development-of-best-in-class-menin-inhibitor-for-aml/
- https://www.eu-startups.com/2025/09/londons-charm-therapeutics-raises-e68-5-million-financing-to-tackle-treatment-resistant-cancers/
- https://www.biopharmadive.com/news/gilead-mirobio-deal-autoimmune/628941/
- https://www.ox.ac.uk/news/2022-08-04-oxford-spinout-mirobio-acquired-gilead-sciences-405m
- https://www.finsmes.com/2024/03/mission-therapeutics-raises-25-2m-in-funding.html
- https://sofinnovapartners.com/news/mission-therapeutics-raises-gbp25-2-million-to-progress-clinical-candidates-in-the-area-of-mitophagy
- https://www.finsmes.com/2010/05/bicycle-therapeutics-receives-additional-seed-funding.html